首页> 外文期刊>Virchows Archiv: an international journal of pathology >Metaplastic mammary carcinoma with osteoclast-like giant cells: identical point mutation of p53 gene only identified in both the intraductal and sarcomatous components.
【24h】

Metaplastic mammary carcinoma with osteoclast-like giant cells: identical point mutation of p53 gene only identified in both the intraductal and sarcomatous components.

机译:具破骨细胞样巨细胞的化生性乳腺癌:p53基因的相同点突变仅在导管内和肉瘤成分中均可识别。

获取原文
获取原文并翻译 | 示例
           

摘要

Metaplastic mammary carcinoma with osteoclast-like giant cells is a rare neoplasm, and the histogenesis of this tumor remains controversial. A case of metaplastic mammary carcinoma with osteoclast-like giant cells in a 72-year-old woman is reported with p53 mutational analysis. Microscopically, the tumor was composed of a dominant sarcomatous stromal component containing osteoclast-like giant cells and a minor component of intraductal carcinoma. Immunostaining for p53 revealed strong positivity in both intraductal and sarcomatous components, but not in osteoclast-like giant cells. Mutational analysis of the p53 gene disclosed an identical point mutation in both intraductal and sarcomatous components, but not in osteoclast-like giant cells, indicating that both components share the same progenitor cells, and osteoclast-like giant cells represent a reactive infiltrate.
机译:具有破骨细胞样巨细胞的化生性乳癌是一种罕见的肿瘤,该肿瘤的组织发生仍存在争议。用p53突变分析报道了一例72岁女性的破骨细胞样巨细胞化生性乳腺癌。在显微镜下,该肿瘤由占优势的肉瘤基质成分组成,该成分包含破骨细胞样巨细胞和导管内癌的次要成分。 p53的免疫染色在导管内和肉瘤成分中均显示出强阳性,但在破骨细胞样巨细胞中却没有。 p53基因的突变分析显示,在导管内和肉瘤成分中都存在相同的点突变,但在破骨细胞样巨细胞中却没有,这表明这两种成分共享相同的祖细胞,破骨细胞样巨细胞代表了反应性浸润。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号